PT  - JOURNAL ARTICLE
AU  - Rahmandad, Hazhir
AU  - Lim, Tse Yang
AU  - Sterman, John
TI  - Estimating COVID-19 under-reporting across 86 nations: implications for projections and control
AID  - 10.1101/2020.06.24.20139451
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.24.20139451
4099  - http://medrxiv.org/content/early/2020/08/03/2020.06.24.20139451.short
4100  - http://medrxiv.org/content/early/2020/08/03/2020.06.24.20139451.full
AB  - COVID-19 prevalence and mortality remain uncertain. For all 86 countries with reliable testing data we estimate how asymptomatic transmission, disease acuity, hospitalization, and behavioral responses to risk shape pandemic dynamics. Estimated cumulative cases and deaths through 10 July 2020 are 10.5 and 1.47 times official reports, yielding an infection fatality rate (IFR) of 0.65%, with wide variation across nations. Despite underestimation, herd immunity remains distant. Sufficient early testing could have averted 39.7 (35.3-45.3) million cases and 218 (191-257) thousand deaths. Responses to perceived risk cause the reproduction number to settle near 1, but with very different steady-state incidence, while some nations experience endogenous rebounds. Scenarios through March 2021 show modest enhancements in responsiveness could reduce cumulative cases ≈80%, to 271 (254-412) million across these nations.One Sentence Summary COVID-19 under-reporting is large, varies widely across nations, and strongly conditions projected outbreak dynamics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was used to conduct this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, codes, and simulation models are publicly available. https://github.com/tseyanglim/CovidGlobal